Wellcome Sanger Institute
Wellcome Sanger Institute, Open Targets Fund Inflammatory Bowel Disease Biomarker Study
Researchers will analyze multiomic and clinical data from 1,000 patients with IBD recruited from seven participating hospitals in the UK.
UK, Australian Researchers ID Tumor-Agnostic Microbiome Signature to Predict Opdivo-Yervoy Response
Premium
Researchers uncovered 22 bacteria that could predict which patients do and do not respond to combination checkpoint inhibitors across diverse cancer types.
A Cambridge University study found phrases touting the benefits of genomics research without acknowledging limitations can turn off the very people researchers need to engage most.
Deciphering Developmental Disorders Study Provides Molecular Diagnosis to 41 Percent of Patients
Members of the DDD study team diagnosed more than 5,500 children with rare diseases from the UK and Ireland using exome sequencing and microarrays.
Microbiotica Raises $66M in Series B Funding
The Cambridge-based firm will put the funds toward clinical trials of its precision microbiome-based therapies, including its immuno-oncology candidate MB097.